BioMarin Pharmaceutical, Inc. (BMRN)
57.81
-0.32
(-0.55%)
USD |
NASDAQ |
Feb 09, 16:00
57.82
+0.01
(+0.02%)
After-Hours: 20:00
BioMarin Pharmaceutical Price : 57.81 for Feb. 9, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Amicus Therapeutics, Inc. | 14.30 |
| Merck & Co., Inc. | 117.65 |
| Gilead Sciences, Inc. | 151.68 |
| AbbVie, Inc. | 223.26 |
| Amgen, Inc. | 375.82 |
Price Related Metrics
| PE Ratio | 21.66 |
| PS Ratio | 3.664 |
| PEG Ratio | 0.3568 |
| Price to Book Value | 1.834 |
| Price to Free Cash Flow | 13.69 |
| Earnings Yield | 4.62% |
| Market Cap | 11.11B |
| PEGY Ratio | 0.3568 |
| Operating PE Ratio | 13.21 |
| Normalized PE Ratio | 16.20 |